Single High-Sensitivity Cardiac Troponin I to Rule Out Acute Myocardial Infarction

Yader Sandoval1, Stephen W Smith2, Sara A Love3

  • 1Division of Cardiology, Hennepin County Medical Center and Minneapolis Heart Institute, Abbott Northwestern Hospital, Minn.

Insights

Single high-sensitivity cardiac troponin I (hs-cTnI) measurements effectively rule out acute myocardial infarction. These strategies identify patients with a very low risk of adverse events within 30 days.

Area of Science:

  • Cardiology
  • Biomarkers
  • Emergency Medicine

Background:

  • Acute myocardial infarction (AMI) diagnosis relies on sensitive biomarkers.
  • High-sensitivity cardiac troponin I (hs-cTnI) assays offer improved diagnostic performance.
  • Evaluating single hs-cTnI measurement strategies is crucial for efficient emergency department workflows.

Purpose of the Study:

  • To assess the performance of single hs-cTnI measurement strategies for ruling out AMI.
  • To determine the negative predictive value (NPV) and sensitivity of hs-cTnI for Type 1 and Type 2 AMI.
  • To evaluate the safety outcome (AMI or cardiac death at 30 days) associated with hs-cTnI thresholds.

Main Methods:

  • Prospective, observational study of 1631 emergency department patients.
  • Utilized an investigational hs-cTnI assay for serial measurements.
  • Analyzed hs-cTnI levels below the limit of detection (<1.9 ng/L) and a 5 ng/L threshold, with and without normal ECG.

Main Results:

  • hs-cTnI < Limit of Detection (LoD) showed 99.6% NPV and 98.8% sensitivity for AMI.
  • hs-cTnI < 5 ng/L demonstrated 98.9% NPV and 94.7% sensitivity for AMI.
  • Combining hs-cTnI thresholds with normal ECG yielded high NPV and sensitivity for both AMI and safety outcomes.

Conclusions:

  • Single hs-cTnI measurements, alone or with normal ECG, can rapidly identify low-risk patients for AMI.
  • These strategies facilitate early identification of patients unlikely to experience adverse cardiac events.
  • The findings support the use of hs-cTnI in streamlined protocols for ruling out AMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
351
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
582
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
392
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
356